Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Warner Bros
WBD
|
+$130M |
| 2 |
Tesla
TSLA
|
+$76.4M |
| 3 |
Roblox
RBLX
|
+$50.1M |
| 4 |
VICI Properties
VICI
|
+$43.2M |
| 5 |
Danaher
DHR
|
+$41.2M |
Top Sells
| 1 |
AT&T
T
|
+$209M |
| 2 |
CERN
Cerner Corp
CERN
|
+$119M |
| 3 |
Baidu
BIDU
|
+$91.9M |
| 4 |
Canadian National Railway
CNI
|
+$53.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$37.5M |
Sector Composition
| 1 | Technology | 26.45% |
| 2 | Healthcare | 15.87% |
| 3 | Consumer Discretionary | 11.68% |
| 4 | Communication Services | 8.96% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Cogent Communications
CCOI
$1.74B
| $6.16M | ﹤0.01% |
101,400
| – | – |
|
|
IBTX
1202
DELISTED
Independent Bank Group, Inc.
IBTX
| $6.15M | ﹤0.01% |
90,622
+4,400
| +5% | +$299K |
|
1203
Pacira BioSciences
PCRX
$1.23B
| $6.14M | ﹤0.01% |
105,300
| – | – |
|
|
MRTX
1204
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.13M | ﹤0.01% |
91,300
| – | – |
|
1205
Neogen
NEOG
$1.22B
| $6.12M | ﹤0.01% |
254,232
| – | – |
|
1206
Sanmina
SANM
$6.29B
| $6.1M | ﹤0.01% |
149,700
-2,500
| -2% | -$102K |
|
1207
Atlantic Union Bankshares
AUB
$5.03B
| $6.07M | ﹤0.01% |
178,847
| – | – |
|
1208
Mr. Cooper
COOP
$14.1B
| $6.07M | ﹤0.01% |
165,100
+23,000
| +16% | +$845K |
|
1209
PTC Therapeutics
PTCT
$4.86B
| $6.06M | ﹤0.01% |
151,265
+800
| +0.5% | +$32.1K |
|
1210
MP Materials
MP
$11.2B
| $6.05M | ﹤0.01% |
188,600
+41,500
| +28% | +$1.33M |
|
1211
SITE Centers
SITC
$471M
| $6.03M | ﹤0.01% |
573,968
+61,781
| +12% | +$649K |
|
1212
Champion Homes, Inc.
SKY
$4.25B
| $6.03M | ﹤0.01% |
127,200
+6,400
| +5% | +$303K |
|
|
NUVA
1213
DELISTED
NuVasive, Inc.
NUVA
| $6.01M | ﹤0.01% |
122,269
| – | – |
|
1214
SiTime
SITM
$6.69B
| $6M | ﹤0.01% |
36,800
+5,700
| +18% | +$929K |
|
1215
Columbia Sportswear
COLM
$3B
| $5.98M | ﹤0.01% |
83,600
-1,300
| -2% | -$93.1K |
|
1216
Chegg
CHGG
$173M
| $5.97M | ﹤0.01% |
317,600
-25,100
| -7% | -$471K |
|
1217
Commault Systems
CVLT
$7.93B
| $5.94M | ﹤0.01% |
94,500
-2,300
| -2% | -$145K |
|
1218
Denali Therapeutics
DNLI
$2.15B
| $5.93M | ﹤0.01% |
201,400
+13,700
| +7% | +$403K |
|
1219
Otter Tail
OTTR
$3.52B
| $5.92M | ﹤0.01% |
88,200
-10,000
| -10% | -$671K |
|
1220
Albany International
AIN
$1.75B
| $5.91M | ﹤0.01% |
75,000
-1,600
| -2% | -$126K |
|
1221
NETSCOUT
NTCT
$1.82B
| $5.89M | ﹤0.01% |
173,928
-800
| -0.5% | -$27.1K |
|
1222
Nova
NVMI
$8.59B
| $5.88M | ﹤0.01% |
67,844
+70
| +0.1% | +$6.07K |
|
1223
Steven Madden
SHOO
$2.23B
| $5.87M | ﹤0.01% |
182,125
-10,300
| -5% | -$332K |
|
1224
Ingevity
NGVT
$2.12B
| $5.87M | ﹤0.01% |
92,890
| – | – |
|
1225
MaxLinear
MXL
$1.38B
| $5.86M | ﹤0.01% |
172,373
| – | – |
|